Pacific Biosciences Of California (PACB) Profit After Tax (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Profit After Tax of -$8.3 million for Q1 2026, down 20082.93% year-over-year from N/an in Q1 2025, and up 79.5% quarter-over-quarter from -$40.4 million in Q4 2025.
Pacific Biosciences Of California (PACB) Profit After Tax (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Profit After Tax history runs 17 years deep, the most recent figure standing at -$8.3 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 20082.93% year-over-year to -$8.3 million; the TTM figure through Mar 2026 stood at -$86.6 million (up 49.13% YoY), while the FY2025 annual figure was -$546.4 million, down 76.34% from the prior year.
- Profit After Tax for Q1 2026 stood at -$8.3 million, up from -$40.4 million in the prior quarter.
- The five-year high for Profit After Tax was $2.1 million in Q3 2024, with the low at -$173.3 million in Q2 2024.
- The 5-year median for Profit After Tax is -$69.8 million (2023), against an average of -$56.3 million.
- The sharpest annual moves came in 2024 and 2026: Profit After Tax surged 103.14% in 2024, then sank 20082.93% in 2026.
- Pacific Biosciences Of California's Profit After Tax stood at -$84.4 million in 2022, then advanced by 5.24% to -$80.0 million in 2023, then surged by 101.3% to $1.0 million in 2024, then tumbled by 3993.06% to -$40.4 million in 2025, then jumped by 79.5% to -$8.3 million in 2026.
- Business Quant data shows PACB's Profit After Tax at -$8.3 million in Q1 2026, -$40.4 million in Q4 2025, and -$37.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 573.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 619.54 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | -45.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -45.10 Mn |
| Mar 31, 2026 | -8.28 Mn |
| Dec 31, 2025 | -40.37 Mn |
| Sep 30, 2025 | -37.85 Mn |
| Jun 30, 2025 | -114,000.00 |
| Mar 31, 2025 | -41,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | -173.32 Mn |
| Mar 31, 2024 | -78.70 Mn |
| Dec 31, 2023 | -79.96 Mn |
| Sep 30, 2023 | -66.02 Mn |
| Jun 30, 2023 | -69.83 Mn |
| Mar 31, 2023 | -88.02 Mn |
| Dec 31, 2022 | -84.38 Mn |
| Sep 30, 2022 | -77.77 Mn |
| Jun 30, 2022 | -71.39 Mn |
| Mar 31, 2022 | -84.50 Mn |
| Dec 31, 2021 | -69.33 Mn |
| Jun 30, 2021 | -41.00 Mn |